🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Determine the effects of escalated dose of daunorubicin in induction treatm...
Status
Completed
Location
Asan Medical Center
Start Date
2001-08
Trial ID
NCT00474006
Treatments Being Tested
The primary purpose of the study will be testing the dosing of temozolomide...
Status
Terminated
Location
Cedars Sinai Medical Center
Start Date
2010-10-14
Trial ID
NCT01235793
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
The purpose of this study is to assess if adding revumenib to standard chem...
Status
Recruiting
Location
Clinical Trial Site
Start Date
2025-11-25
Trial ID
NCT07211958
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-11
Trial ID
NCT00077116
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Algemeen Ziekenhuis Middelheim
Start Date
1993-03
Trial ID
NCT00002517
This is a prospective phase II, single-arm clinical study that plans to enr...
Status
Unknown
Location
The Second Affiliated Hospital of Kunming Medical University.
Start Date
2023-04-01
Trial ID
NCT05949762
Treatments Being Tested
This is a phase 1, first-in-human (FIH), open-label, multicohort study to e...
Status
Completed
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2023-07-31
Trial ID
NCT05987696
Treatments Being Tested
This is a Phase I/II study to determine the safety, tolerability and to ide...
Status
Terminated
Location
The Cancer Institute of New Jersey
Start Date
2007-11
Trial ID
NCT00780143
Treatments Being Tested